This recognition highlights VELP’s ongoing commitment to sustainability, encompassing environmental stewardship, ethical business practices, labor and human rights, and responsible procurement strategies. VELP Scientifica is proud to announce that it has been awarded the Bronze Medal from EcoVadis, a leading organization in sustainability performance ratings. With over 130,000 companies assessed worldwide, this acknowledgment underscores VELP’s dedication to improving its sustainability efforts. […]

— Nirrin Technologies, a developer of analytical tools poised to transform bioprocess analysis, today announced the founding of its Scientific Advisory Board (SAB), with key experts in diverse fields across biomanufacturing and advanced therapeutic development joining as inaugural members. The SAB will provide technical and strategic guidance for ongoing research and development programs and shape plans for […]

SAN JOSE, Calif. — In 2024, Complete Genomics, a pioneering genomic sequencing company, expanded its U.S. manufacturing footprint with augmented technology capabilities to diversify its supply chain helping it to continue reliably serving customers with flexible, cost-effective next generation sequencing (NGS) solutions. Expanding U.S. manufacturing capabilities in 2024 and beyond After weathering a year of geopolitical […]

SAN DIEGO – Nucleus Biologics, a leader in precision cell culture media development, is proud to announce that it has achieved an industry-leading quality milestone. It has received EXCiPACT certification for Pharmaceutical Excipients and Pharmaceutical Auxiliary Materials (PAMs) and ISO 9001 certification from SGS. This Excipient GMP certification will better support the cell culture media, buffers, […]

ST. PAUL, Minn. — ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation, today announced that Seattle Children’s Therapeutics, a division of the Seattle Children’s Research Institute has been awarded a $125,000 G-Rex Grant.  The G-Rex Grant will integrate state-of-the-art advancements into Seattle Children’s Therapeutics’ G-Rex based CAR-T cell platform. “This technology has been a […]

CHADDS FORD, Pa. — MOBILion Systems, Inc., a leader in separation science innovation, today announced that as of December 2024, its foundational Structures for Lossless Ion Manipulation (SLIM) platform technology reached the milestone of being highlighted in 100 peer-reviewed publications in leading journals such as Journal of the American Society for Mass Spectrometry, Analytical Chemistry, and International Journal […]

HDS certification underscores Sapio Sciences’ commitment to data security BALTIMORE, MD — Sapio Sciences, the science-awareTM lab informatics platform, today announced its achievement of the Hébergeur de Données de Santé (HDS) certification, a mandatory requirement for organizations hosting personal health data in France. Achieving HDS certification underscores Sapio Sciences’ compliance with stringent security, privacy, and operational continuity standards. […]

Hamilton, a global leader in life science technologies, is pleased to announce the launch of Hamilton Company Australia (Hamilton Australia), a wholly-owned subsidiary based in Sydney, as part of its international expansion. This new subsidiary will enhance collaboration with Hamilton’s US headquarters and provide customers with direct access to Hamilton’s industry-leading automated solutions and services. […]

NORTHPORT, N.Y. — FireflySci Inc., a small American-based manufacturer of high-quality quartz cuvettes for spectroscopy, has announced a necessary price adjustment following the introduction of proposed import tariffs by President-elect Donald Trump. Starting January 1 2025, FireflySci will increase prices by 20% across its product range. These proposed tariffs, aimed at reshaping international trade relationships and encouraging domestic manufacturing, are expected […]

Proprietary Next-Generation Non-Viral, Non-Electroporative Transfection Platform Gaining Traction in Cell Therapy Market ALAMEDA, Calif.–CellFE®, a disruptive life sciences company marketing non-viral, non-electroporative cell therapy manufacturing tools, today announced several strategic system placements with major pharmaceutical and biotech companies, as well as leading translational medicine centers in the cell therapy market. These placements follow the successful […]